Advertisement
HealthDay Reports: NIH — Large-Scale Testing of Some COVID-19 Vaccines Could Start in July

NFL Urges Teams to Offer Stadiums as Vaccination Centers

0

NFL would benefit from Americans being vaccinated because it increases the odds that state officials will reopen stadiums

La vacuna de Pfizer contra la COVID parece promisoria

Number of U.S. Adults Willing to Take COVID-19 Vaccine Down

0

Findings based on a biweekly survey conducted from April through December

Could the TB Vaccine Help Prevent COVID-19?

Two-Thirds of Lupus Patients Likely to Take COVID-19 Vaccine

0

However, national survey uncovered racial differences in uptake, safety concerns

Antibiotic Therapy Before Age 2 May Affect Child Health

Pandemic-Related MMR Vaccine Decline Persists

0

Authors say catch-up strategies are necessary to ensure young children receive preventive care

Drug Makers Raise Prices on 500 Prescription Drugs

0

AbbVie, Bristol Myers Squibb, GlaxoSmithKline, and Pfizer among companies raising their prices by a median of 4.6 percent

U.S. Health Care Spending Increased 4.6 Percent in 2019

0

Growth rate similar to that experienced in 2018 and consistent with growth rate since 2016

Are We Getting Closer to a Herpes Vaccine?

Top FDA Officials Say Two Full Doses of COVID-19 Vaccines a Must

0

Agency says it is understandable that people may want to stretch the vaccine supply, but it is not safe to do so

Okada Test Article

Euglycemic DKA ID’d in T2DM Patients With COVID-19

0

Five cases of euDKA identified in patients with type 2 diabetes using SGLT2 inhibitors who developed SARS-CoV-2 infection

Radiation Rx for Prostate Cancer Can Cause Financial Pain: Study

Single-Drug Regimen Now Advised for Uncomplicated Gonorrhea

0

Single 500-mg intramuscular dose of ceftriaxone recommended for uncomplicated urogenital, anorectal, pharyngeal gonorrhea

ASH: Daratumumab + Pomalidomide

mRNA-1273 Vaccine Highly Effective for Preventing COVID-19

0

Published data on Moderna vaccine show severe COVID-19 in 30 individuals -- all in the placebo group -- in trial of 30,420 participants